Photosensitive Epilepsy Completed Phase 2 Trials for Levetiracetam (DB01202)

IndicationStatusPhase
DBCOND0039388 (Photosensitive Epilepsy)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00894010Photosensitivity Proof of Concept TrialTreatment